We develop and deliver mobile shopper marketing and analytics solutions for the business to consumer B C marketplace leveraging mobile, social media, gamification and our intellectual property portfolio. We have developed a patented technology platform that enables brands and retailers to engage with shoppers when they are on the path to purchase products and services. Our technology also allows brands to leverage customer relationships and brand advocacy to increase brand loyalty and drive revenue through sharing and influencer marketing.
Quote | SAB Biotherapeutics Inc Com (OTCMKTS:BCYP)
Last: | $ |
---|---|
Change Percent: | 31.20% |
Open: | $0.01312 |
Close: | $0.01312 |
High: | $0.01312 |
Low: | $0.01312 |
Volume: | 714 |
Last Trade Date Time: | 12/05/2019 04:14:54 pm |
News | SAB Biotherapeutics Inc Com (OTCMKTS:BCYP)
SIOUX FALLS, S.D., Aug. 21, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics ( Nasdaq: SABS ), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human...
SAB highlights results from GLP toxicology study confirming SAB-142's mechanism of action at the 23rd Federation of Clinical Immunology Societies (FOCIS) Study shows SAB’s fully-human multi-target immune modulating therapeutic for treatment of Type 1 Diabetes is well tolerated ...
Message Board Posts | SAB Biotherapeutics Inc Com (OTCMKTS:BCYP)
Subject | By | Source | When |
---|---|---|---|
BCYP: Charter Cancelled / Dissolution | Renee | investorshub | 01/31/2020 10:56:40 PM |
BCYP bullish 0.1580 | stocktrademan | investorshub | 04/09/2017 8:47:11 PM |
Agreed. No catalysts left, nowhere else to go. | thegreatnicoli | investorshub | 12/24/2016 8:37:46 AM |
Looks to me the end is near. EOM | nhra3361 | investorshub | 12/20/2016 11:00:31 PM |
Blue Calypso to Explore Strategic Alternatives | maddawg2020 | investorshub | 12/20/2016 5:33:39 PM |
News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Inc Com Company Name:
BCYP Stock Symbol:
OTCMKTS Market:
SAB Biotherapeutics Inc Com Website:
SIOUX FALLS, S.D., Aug. 21, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics ( Nasdaq: SABS ), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulins (hIgG), also known as fully-human...
SAB highlights results from GLP toxicology study confirming SAB-142's mechanism of action at the 23rd Federation of Clinical Immunology Societies (FOCIS) Study shows SAB’s fully-human multi-target immune modulating therapeutic for treatment of Type 1 Diabetes is well tolerated ...
SIOUX FALLS, S.D., May 30, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS ), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human immunoglobulin (hIgG) antibodies (fully-human polyc...